Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Differential response of lung cancer cell lines to vitamin D derivatives depending on EGFR, KRAS, p53 mutation status and VDR polymorphism.

Maj E, Trynda J, Maj B, Gębura K, Bogunia-Kubik K, Chodyński M, Kutner A, Wietrzyk J.

J Steroid Biochem Mol Biol. 2019 Oct;193:105431. doi: 10.1016/j.jsbmb.2019.105431. Epub 2019 Jul 18.

2.

Variability within the human TERT gene, telomere length and predisposition to chronic lymphocytic leukemia.

Wysoczanska B, Dratwa M, Gebura K, Mizgala J, Mazur G, Wrobel T, Bogunia-Kubik K.

Onco Targets Ther. 2019 May 31;12:4309-4320. doi: 10.2147/OTT.S198313. eCollection 2019.

3.

ECCR1 and NFKB2 Polymorphisms as Potential Biomarkers of Non-small Cell Lung Cancer in a Polish Population.

Chaszczewska-Markowska M, Kosacka M, Chryplewicz A, Dyła T, Brzecka A, Bogunia-Kubik K.

Anticancer Res. 2019 Jun;39(6):3269-3272. doi: 10.21873/anticanres.13469.

PMID:
31177178
4.

G-CSF administration favours SDF-1 release and activation of neutrophils and monocytes in recipients of autologous peripheral blood progenitor cells.

Gębura K, Butrym A, Chaszczewska-Markowska M, Wróbel T, Kuliczkowski K, Bogunia-Kubik K.

Cytokine. 2019 Apr;116:38-47. doi: 10.1016/j.cyto.2018.12.011. Epub 2019 Jan 24.

PMID:
30685602
5.

Interleukin 6 gene polymorphism is associated with protein serum level and disease activity in Polish patients with rheumatoid arthritis.

Wielińska J, Dratwa M, Świerkot J, Korman L, Iwaszko M, Wysoczańska B, Bogunia-Kubik K.

HLA. 2018 Dec;92 Suppl 2:38-41. doi: 10.1111/tan.13355.

PMID:
30054992
6.

Genetic aspects of primary hyperaldosteronism.

Korzyńska W, Jodkowska A, Gosławska K, Bogunia-Kubik K, Mazur G.

Adv Clin Exp Med. 2018 Aug;27(8):1149-1158. doi: 10.17219/acem/69390. Review.

7.

Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Ciechomska M, Bonek K, Merdas M, Zarecki P, Swierkot J, Gluszko P, Bogunia-Kubik K, Maslinski W.

Arch Immunol Ther Exp (Warsz). 2018 Oct;66(5):389-397. doi: 10.1007/s00005-018-0513-y. Epub 2018 May 9.

8.

BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients.

Łacina P, Butrym A, Mazur G, Bogunia-Kubik K.

Genes (Basel). 2018 Apr 24;9(5). pii: E226. doi: 10.3390/genes9050226.

9.

Genetically determined enlargement of carotid body evaluated using computed angiotomography.

Jaźwiec P, Gać P, Chaszczewska-Markowska M, Bogunia-Kubik K, Mazur G, Poręba R.

Respir Physiol Neurobiol. 2018 Aug;254:10-15. doi: 10.1016/j.resp.2018.04.001. Epub 2018 Apr 5.

PMID:
29627490
10.

Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia.

Butrym A, Łacina P, Kuliczkowski K, Bogunia-Kubik K, Mazur G.

BMC Cancer. 2018 Jan 30;18(1):107. doi: 10.1186/s12885-018-4045-y.

11.

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis.

Iwaszko M, Świerkot J, Kolossa K, Jeka S, Wiland P, Bogunia-Kubik K.

Genes (Basel). 2018 Jan 25;9(2). pii: E64. doi: 10.3390/genes9020064.

12.

Polymorphisms within Genes Involved in Regulation of the NF-κB Pathway in Patients with Rheumatoid Arthritis.

Gębura K, Świerkot J, Wysoczańska B, Korman L, Nowak B, Wiland P, Bogunia-Kubik K.

Int J Mol Sci. 2017 Jul 4;18(7). pii: E1432. doi: 10.3390/ijms18071432.

13.

The role of microRNA-5196 in the pathogenesis of systemic sclerosis.

Ciechomska M, Zarecki P, Merdas M, Swierkot J, Morgiel E, Wiland P, Maslinski W, Bogunia-Kubik K.

Eur J Clin Invest. 2017 Aug;47(8):555-564. doi: 10.1111/eci.12776. Epub 2017 Jul 18.

14.

From genetic single candidate gene studies to complex genomics of GvHD.

Bogunia-Kubik K, Łacina P.

Br J Haematol. 2017 Sep;178(5):661-675. doi: 10.1111/bjh.14704. Epub 2017 Apr 26. Review.

PMID:
28444735
15.

bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients.

Wróbel T, Butrym A, Łacina P, Rybka J, Gębura K, Mazur G, Bogunia-Kubik K.

Anticancer Res. 2017 Apr;37(4):1799-1803.

PMID:
28373444
16.

Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma.

Butrym A, Łacina P, Rybka J, Chaszczewska-Markowska M, Mazur G, Bogunia-Kubik K.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):151-156. doi: 10.1007/s00005-016-0442-6. Epub 2017 Jan 12.

17.

Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis.

Bogunia-Kubik K, Wysoczańska B, Piątek D, Iwaszko M, Ciechomska M, Świerkot J.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):131-136. doi: 10.1007/s00005-016-0443-5. Epub 2017 Jan 12.

18.

Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.

Rogatko-Koroś M, Mika-Witkowska R, Bogunia-Kubik K, Wysoczańska B, Jaskuła E, Kościńska K, Nestorowicz K, Dziopa J, Szlendak U, Gwozdowicz S, Graczyk-Pol E, Lange A, Nowak J.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):63-71. doi: 10.1007/s00005-016-0438-2. Epub 2016 Dec 8.

PMID:
27933342
19.

The renin-angiotensin-aldosterone system (RAAS) - physiology and molecular mechanisms of functioning.

Chaszczewska-Markowska M, Sagan M, Bogunia-Kubik K.

Postepy Hig Med Dosw (Online). 2016 Sep 13;70(0):917-927.

20.

Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.

Butrym A, Gebura K, Iwaszko M, Kuliczkowski K, Bogunia-Kubik K, Mazur G.

HLA. 2016 Jun;87(6):432-8. doi: 10.1111/tan.12810. Epub 2016 May 13.

PMID:
27173875
21.

Variations in genes involved in regulation of the nuclear factor - κB pathway and the risk of acute myeloid leukaemia.

Rybka J, Gębura K, Wróbel T, Wysoczańska B, Stefanko E, Kuliczkowski K, Bogunia-Kubik K.

Int J Immunogenet. 2016 Apr;43(2):101-6. doi: 10.1111/iji.12255. Epub 2016 Feb 25.

PMID:
26919710
22.

Histone Demethylation and Toll-like Receptor 8-Dependent Cross-Talk in Monocytes Promotes Transdifferentiation of Fibroblasts in Systemic Sclerosis Via Fra-2.

Ciechomska M, O'Reilly S, Przyborski S, Oakley F, Bogunia-Kubik K, van Laar JM.

Arthritis Rheumatol. 2016 Jun;68(6):1493-504. doi: 10.1002/art.39602.

23.

Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment.

Butrym A, Rybka J, Łacina P, Gębura K, Frontkiewicz D, Bogunia-Kubik K, Mazur G.

Leuk Res. 2015 Dec;39(12):1462-6. doi: 10.1016/j.leukres.2015.10.007. Epub 2015 Oct 19.

PMID:
26521987
24.

Application of (1)H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis.

Zabek A, Swierkot J, Malak A, Zawadzka I, Deja S, Bogunia-Kubik K, Mlynarz P.

J Pharm Biomed Anal. 2016 Jan 5;117:544-50. doi: 10.1016/j.jpba.2015.10.007. Epub 2015 Oct 14.

25.

Influence of CD94 and NKG2A variants on susceptibility to rheumatoid arthritis and efficacy of anti-TNF treatment.

Iwaszko M, Świerkot J, Kolossa K, Jeka S, Wiland P, Bogunia-Kubik K.

Joint Bone Spine. 2016 Jan;83(1):75-9. doi: 10.1016/j.jbspin.2015.06.010. Epub 2015 Oct 6.

PMID:
26453102
26.

Polymorphisms within the human leucocyte antigen-E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy.

Iwaszko M, Świerkot J, Kolossa K, Jeka S, Wiland P, Bogunia-Kubik K.

Clin Exp Immunol. 2015 Dec;182(3):270-7. doi: 10.1111/cei.12696. Epub 2015 Sep 28.

27.

Beneficial effect of the CXCL12-3'A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors.

Bogunia-Kubik K, Mizia S, Polak M, Gronkowska A, Nowak J, Kyrcz-Krzemień S, Markiewicz M, Dzierżak-Mietła M, Koclęga A, Sędzimirska M, Suchnicki K, Duda D, Lange J, Mordak-Domagała M, Kościńska K, Jędrzejczak WW, Kaczmarek B, Hellmann A, Kucharska A, Kowalczyk J, Drabko K, Warzocha K, Hałaburda K, Tomaszewska A, Mika-Witkowska R, Witkowska A, Goździk J, Mordel A, Wysoczańska B, Jaskula E, Lange A; POLISH DONOR–RECIPIENT STUDY GROUP.

Cytokine. 2015 Dec;76(2):182-186. doi: 10.1016/j.cyto.2015.05.001. Epub 2015 May 14.

PMID:
25982843
28.

CCR5 gene polymorphism affects the risk of GvHD after haematopoietic stem cell transplantation from an unrelated donor.

Bogunia-Kubik K, Mizia S, Gronkowska A, Nowak J, Kyrcz-Krzemień S, Markiewicz M, Dzierżak-Mietła M, Koclęga A, Sędzimirska M, Suchnicki K, Duda D, Lange J, Mordak-Domagała M, Kościńska K, Węzik S, Jędrzejczak WW, Kaczmarek B, Hellmann A, Kucharska A, Kowalczyk J, Drabko K, Warzocha K, Mika-Witkowska R, Goździk J, Lange A.

Br J Haematol. 2015 Oct;171(2):285-288. doi: 10.1111/bjh.13387. Epub 2015 Mar 30. No abstract available.

PMID:
25823722
29.

Role of the functional MNS16A VNTR-243 variant of the human telomerase reverse transcriptase gene in progression and response to therapy of patients with non-Hodgkin's B-cell lymphomas.

Wysoczanska B, Wrobel T, Dobrzynska O, Mazur G, Bogunia-Kubik K.

Int J Immunogenet. 2015 Apr;42(2):100-5. doi: 10.1111/iji.12182. Epub 2015 Feb 12.

PMID:
25684018
30.

Elevated level of HSPA1L mRNA correlates with graft-versus-host disease.

Atarod S, Turner B, Pearce KF, Ahmed SS, Norden J, Bogunia-Kubik K, Wang XN, Collin M, Dickinson AM.

Transpl Immunol. 2015 Jun;32(3):188-94. doi: 10.1016/j.trim.2015.02.002. Epub 2015 Feb 11.

PMID:
25680846
31.

Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.

Nowak J, Kościńska K, Mika-Witkowska R, Rogatko-Koroś M, Mizia S, Jaskuła E, Polak M, Mordak-Domagała M, Lange J, Gronkowska A, Jędrzejczak WW, Kyrcz-Krzemień S, Markiewicz M, Dzierżak-Mietła M, Tomaszewska A, Nasiłowska-Adamska B, Szczepiński A, Hałaburda K, Hellmann A, Czyż A, Gil L, Komarnicki M, Wachowiak J, Barańska M, Kowalczyk J, Drabko K, Goździk J, Wysoczańska B, Bogunia-Kubik K, Graczyk-Pol E, Witkowska A, Marosz-Rudnicka A, Nestorowicz K, Dziopa J, Szlendak U, Warzocha K, Lange A; Polish Donor-Recipient Matching Study Group.

Biol Blood Marrow Transplant. 2015 May;21(5):829-39. doi: 10.1016/j.bbmt.2015.01.018. Epub 2015 Jan 21.

32.

MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis.

Ciechomska M, O'Reilly S, Suwara M, Bogunia-Kubik K, van Laar JM.

PLoS One. 2014 Dec 30;9(12):e115596. doi: 10.1371/journal.pone.0115596. eCollection 2014.

33.

Significance of association of HLA-C and HLA-E with psoriatic arthritis.

Sokolik R, Gębura K, Iwaszko M, Świerkot J, Korman L, Wiland P, Bogunia-Kubik K.

Hum Immunol. 2014 Dec;75(12):1188-91. doi: 10.1016/j.humimm.2014.10.005. Epub 2014 Oct 16.

PMID:
25454626
34.

IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis.

Bogunia-Kubik K, Świerkot J, Malak A, Wysoczańska B, Nowak B, Białowąs K, Gębura K, Korman L, Wiland P.

Arch Immunol Ther Exp (Warsz). 2015 Jun;63(3):215-21. doi: 10.1007/s00005-014-0319-5. Epub 2014 Nov 12.

35.

Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis.

Swierkot J, Bogunia-Kubik K, Nowak B, Bialowas K, Korman L, Gebura K, Kolossa K, Jeka S, Wiland P.

Joint Bone Spine. 2015 Mar;82(2):94-9. doi: 10.1016/j.jbspin.2014.08.006. Epub 2014 Oct 11.

PMID:
25311255
36.

[Paraneoplastic syndromes and rheumatic diseases].

Swierkot J, Lewandowicz-Uszyńska A, Bogunia-Kubik K.

Postepy Hig Med Dosw (Online). 2014 Jul 4;68:944-54. Review. Polish.

37.

Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.

Nowak J, Kościńska K, Mika-Witkowska R, Rogatko-Koroś M, Mizia S, Jaskuła E, Polak M, Mordak-Domagała M, Lange J, Gronkowska A, Jędrzejczak WW, Kyrcz-Krzemień S, Markiewicz M, Dzierżak-Mietła M, Tomaszewska A, Nasiłowska-Adamska B, Szczepiński A, Hałaburda K, Hellmann A, Komarnicki M, Gil L, Czyż A, Wachowiak J, Barańska M, Kowalczyk J, Drabko K, Goździk J, Wysoczańska B, Bogunia-Kubik K, Graczyk-Pol E, Witkowska A, Marosz-Rudnicka A, Nestorowicz K, Dziopa J, Szlendak U, Warzocha K, Lange AA; Polish Donor-Recipient Matching Study Group.

Am J Hematol. 2014 Oct;89(10):E176-83. doi: 10.1002/ajh.23802. Epub 2014 Aug 27.

38.

IL-17F gene polymorphism is associated with susceptibility to acute myeloid leukemia.

Wróbel T, Gębura K, Wysoczańska B, Jaźwiec B, Dobrzyńska O, Mazur G, Kuliczkowski K, Bogunia-Kubik K.

J Cancer Res Clin Oncol. 2014 Sep;140(9):1551-5. doi: 10.1007/s00432-014-1674-7. Epub 2014 May 3.

39.

[Tumors in rheumatic diseases].

Świerkot J, Lewandowicz-Uszyńska A, Bogunia-Kubik K.

Postepy Hig Med Dosw (Online). 2013 Dec 11;67:1254-60. Review. Polish.

40.

VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma.

Wróbel T, Mazur G, Dzietczenia J, Gębura K, Kuliczkowski K, Bogunia-Kubik K.

Biomed Res Int. 2013;2013:159813. doi: 10.1155/2013/159813. Epub 2013 Aug 26.

41.

The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma.

Mazur G, Gębura K, Gieryng A, Butrym A, Wróbel T, Bogunia-Kubik K.

Cytokine. 2013 Oct;64(1):422-6. doi: 10.1016/j.cyto.2013.05.004. Epub 2013 May 24.

PMID:
23711392
42.

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

Wróbel T, Mazur G, Dzietczenia J, Gebura K, Kuliczkowski K, Bogunia-Kubik K.

Med Oncol. 2013 Mar;30(1):456. doi: 10.1007/s12032-013-0456-4. Epub 2013 Jan 19.

43.

16(th) IHIW: immunogenetics of aging.

Naumova E, Ivanova M, Pawelec G, Constantinescu I, Bogunia-Kubik K, Lange A, Oguz F, Ozdilli K, Franceschi C, Caruso C, Mishra M, Middleton D.

Int J Immunogenet. 2013 Feb;40(1):77-81. doi: 10.1111/iji.12027.

PMID:
23302099
44.

Genetic variant of the G-CSF receptor gene is associated with lower mobilization potential and slower recovery of granulocytes after transplantation of autologous peripheral blood progenitor cells.

Bogunia-Kubik K, Gieryng A, Gebura K, Lange A.

Cytokine. 2012 Nov;60(2):463-7. doi: 10.1016/j.cyto.2012.06.021. Epub 2012 Jul 15.

PMID:
22796466
45.

[Clinical relevance of chemokine receptor CXCR4].

Gębura K, Bogunia-Kubik K.

Postepy Hig Med Dosw (Online). 2012 May 23;66:252-66. Review. Polish.

46.

[The role of HLA-E polymorphism in immunological response].

Iwaszko M, Bogunia-Kubik K.

Postepy Hig Med Dosw (Online). 2011 Sep 21;65:616-26. Review. Polish.

47.

Clinical significance of the HLA-E and CD94/NKG2 interaction.

Iwaszko M, Bogunia-Kubik K.

Arch Immunol Ther Exp (Warsz). 2011 Oct;59(5):353-67. doi: 10.1007/s00005-011-0137-y. Epub 2011 Jul 29. Review.

PMID:
21800130
48.

'Immunogenetics of Aging': report on the activities of the 15th International HLA and Immunogenetics Working Group and 15th International HLA and Immunogenetics Workshop.

Naumova E, Ivanova M, Pawelec G, Constantinescu I, Bogunia-Kubik K, Lange A, Qguz F, Carin M, Franceschi C, Caruso C, Middleton D.

Tissue Antigens. 2011 Mar;77(3):187-92. doi: 10.1111/j.1399-0039.2010.01603.x.

PMID:
21299522
49.

CXCL12 gene polymorphism and hematologic recovery after transplantation of peripheral blood progenitor cells.

Gieryng A, Bogunia-Kubik K, Lange A.

Transplant Proc. 2010 Oct;42(8):3280-3. doi: 10.1016/j.transproceed.2010.07.021.

PMID:
20970672
50.

Human leukocyte antigen proficiency testing for Central and Eastern Europe: a summary of over 10 years of activity.

Bogunia-Kubik K, Lange A.

Transplant Proc. 2010 Oct;42(8):3263-5. doi: 10.1016/j.transproceed.2010.07.020. Review.

PMID:
20970668

Supplemental Content

Loading ...
Support Center